Sector: MedicalXTNT (NASDAQ: XTNT)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 237 |
Technical : | 228 |
Performance : | 274 |
Overall: | 289 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 231 |
Technical : | 216 |
Performance : | 291 |
Overall: | 287 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 228 |
Technical : | 188 |
Performance : | 292 |
Overall: | 281 |
Number of Stocks: | 306 |
Headlines
- OTC Select Announces NASDAQ Daily Stock Watch - XTEX, VVTV, WIND, XTNT, YAVY
Jun 10, 2009 10:01 AM | VVTV, VYFC, XTEX, XTNT, XTXI
- Xtent CEO: No Surprises In FDA's Draft Stent Guidelines
Mar 27, 2008 11:38 AM | BSX, MDT, XTNT
- Analyst Comments: Penn Virginia Resource, Xtent, PG&E, Ultra Clean, Rogers Communications
Feb 26, 2008 10:17 AM | GM, PCG, PVR, RCII, UCTT, WTW
- Xtent Trading at Fair Value
Aug 22, 2007 07:15 PM | XTNT
- Wait & See on Xtent Shares
Jul 20, 2007 12:36 PM | XTNT
- BenchmarkJournal.Com Free Analyst Review for CMCSK, NVAX, ARUN, CREE, XTNT and CDNS
Aug 14, 2009 08:13 AM | ARUN, CDNS, CMCSA, CMCSK, CREE, NVAX
- XTENT, Inc. Announces That It Has Postponed the Special Meeting of Its Stockholders
Jul 07, 2009 05:56 PM | XTNT
- XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
Jun 04, 2009 06:50 AM | XTNT
- XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials With the SEC
May 15, 2009 05:20 PM | XTNT
- XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
Mar 19, 2009 06:50 AM | XTNT
- XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress
Feb 19, 2009 05:55 PM | XTNT
- XTENT to Retain Investment Bank to Pursue Strategic Alternatives
Jan 23, 2009 06:50 AM | XTNT
- XTENT Announces Third Quarter 2008 Financial Results
Nov 04, 2008 05:00 PM | XTNT
- Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
Oct 13, 2008 03:00 PM | XTNT
- XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
Oct 10, 2008 08:25 PM | XTNT
- Form 4 Marco Philippe H For: Oct 01 (10K)
Oct 01, 2008 08:25 PM
- Form 4 XTENT INC For: Sep 02 Filed by: Marco Philippe H (10K)
Sep 02, 2008 07:20 PM
- Form 4 XTENT INC For: Aug 13 Filed by: Kahlenberg Timothy D (10K)
Aug 15, 2008 06:11 PM
- Form 4 XTENT INC For: Aug 13 Filed by: Andreas Bernard H (10K)
Aug 15, 2008 04:40 PM
- Form 4 XTENT INC For: Aug 13 Filed by: Campbell Randolph E (10K)
Aug 15, 2008 04:37 PM
- Form 4 XTENT INC For: Aug 13 Filed by: Marco Philippe H (10K)
Aug 15, 2008 04:33 PM
- Form 4 XTENT INC For: Aug 01 Filed by: Marco Philippe H (10K)
Aug 04, 2008 05:27 PM
- Form 4 Marco Philippe H For: Jul 01 (10K)
Jul 01, 2008 05:29 PM
- Form 4 XTENT INC For: Jun 18 Filed by: Carusi Michael A (10K)
Jun 20, 2008 04:21 PM
- Form 4 XTENT INC For: Jun 18 Filed by: SPVC VI, LLC (10K)
Jun 20, 2008 11:32 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
XTNT
|
Compare to S&P
|
| YTD |
48.15 %
|
23.95 %
|
| 4 Weeks |
-2.44 %
|
-5.62 %
|
| 12 Weeks |
-56.04 %
|
-59.79 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 18.92 %
|
|
EPS Growth in Last Year: 42.31 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
